AZITHROMYCIN 250mg. IP

An antibiotic with a broader microbial spectrum against many gram-positive and gram-negative bacteria. (Brendan J McMullan, 2015) Active against common lower respiratory tract pathogens including pneumococci, staphylococci, Legionella species, Mycoplasma, and Chlamydia species. (H Lode, 1992) Exerts robust immunomodulatory effects in chronic inflammatory disorders. (Cassondra L Cramer, 2017) A 3-day regimen is effective as 5- to 10-day courses of other more frequently administered antibacterial agents such as erythromycin, amoxicillin-clavulanic acid, and penicillin V. (Barradell, 1996) Exhibits a significantly higher cure rate (70.6% versus 61.1%) than co-amoxiclav for acute exacerbations of chronic bronchitis. (Biebuyck, 1996) A safe and effective alternative in the treatment of inflammatory acne. (Rana Rafiei, 2006) Displays significant improvement in a shorter time with better compliance than with co-amoxiclav. (Biebuyck, 1996) Provides significant reductions in sputum volume, health status, and stabilization of lung function values. (Albert I Lourdesamy Anthony, 2014) More active than erythromycin against many gram-negative pathogens and several other pathogens. (D H Peters, 1992)